Wednesday, September 23, 2015

Exclusive Interview with Larry Couture, VP, Center for Applied Technology Development, City of Hope

Dr. Larry Couture, Vice President of Center for Applied Technology Development, City of Hope - a Keynote Speaker at this years Cell Therapy Bioprocessing & Commercialization Event, sat down to discuss the biggest challenges facing regenerative medicine developers, how pharma companies benefit from learning the academic model for translation, regulatory hurdles, and this years meeting. Below you will find a brief teaser from the interview, to access the full interview, follow the links below...

What are the biggest challenges facing regenerative medicine developers?
Well, the field is really beginning to take off. There are now four or five or six clinical trials and probably at least as many academic trials – some of those are academic – that are about to enter the clinic or will be entering the clinic in the next couple of years. 

One of the problems and challenges that are starting to emerge about where this is going to go and what we are going to have to face and some of the issues we are dealing with right now that I think are going to become big are cost of goods, the ability to scale-up some of the manufacturing processes that we are using purity to sell product. Not necessarily trying to achieve 100% per se, but trying to optimize purity and identify how pure these products should be...[Click here to read more]

Want to hear more from Dr. Couture? Join him in Alexandria, VA for Cell Therapy Bioprocessing & Commercialization, September 30 - October 2, 2015 - where he will have a keynote address titled "Development of a Well Characterized Regenerative Medicine Cell Product". Register now with the code XB15188BLOG to save $100 off the current rate.

See you in Alexandria!

Share this article with your social network, just click below to share now!

No comments :

Post a Comment